Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius SE & Co. KGaA : Comeback of a rising trend ?

share with twitter share with LinkedIn share with facebook
share via e-mail
08/13/2019 | 02:02am EDT
long trade
Live
Entry price : 42.17€ | Target : 47.16€ | Stop-loss : 41€ | Potential : 11.83%
The technical chart pattern of Fresenius SE & Co. KGaA stock suggests the beginning of a trend reversal over the medium term.
Investors have an opportunity to buy the stock and target the € 47.16.
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Summary
  • In a short-term perspective, the company has interesting fundamentals.

Strengths
  • The share is getting closer to its long-term support in weekly data, at EUR 38.99, which offers good timing for buyers.
  • The close medium term support offers good timing for purchasing the stock.
  • Sales forecast by analysts have been recently revised upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • The company's earnings releases usually do not meet expectations.
Ratings chart
Subsector Hospitals, Clinics & Primary Care Services
1st jan.Capitalisation (M$)Investor Rating
FRESENIUS SE & CO. KGAA-0.30%25 858
AIER EYE HOSPITAL GROUP CO ..--.--%13 942
IHH HEALTHCARE BHD--.--%11 881
BANGKOK DUSIT MEDICAL SERVI..--.--%11 862
RAMSAY HEALTH CARE LIMITED19.42%9 410
HAPVIDA PARTICIPACOES E INV..57.05%8 551
NOTRE DAME INTERMEDICA PART..63.00%6 112
TOPCHOICE MEDICAL CORPORATI..98.61%4 285
-
MEDICLINIC INTERNATIONAL-5.61%2 709
THE ENSIGN GROUP, INC.33.48%2 706
APOLLO HOSPITALS ENTERPRISE..16.87%2 642
Autres valeurs du secteur

Ulrich Ebensperger
© Zonebourse.com 2019
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (EUR)
Sales 2019 35 505 M
EBIT 2019 4 666 M
Net income 2019 1 836 M
Debt 2019 20 580 M
Yield 2019 1,87%
P/E ratio 2019 12,8x
P/E ratio 2020 11,7x
EV / Sales2019 1,25x
EV / Sales2020 1,11x
Capitalization 23 686 M
Upcoming event on FRESENIUS SE & CO. KGAA
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 56,94  €
Last Close Price 42,52  €
Spread / Highest target 75,9%
Spread / Average Target 33,9%
Spread / Lowest Target -23,7%
EPS Revisions
Managers
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board